A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism.

Fady Allahwerdy Steven Pan Michael Feehan Aubrey E Jones Mark A Munger Daniel M Witt

Published in: Pharmacy practice (2019)

In this national sample of recent VTE sufferers warfarin therapy remains the most used anticoagulant followed closely by DOAC therapy. Switching between warfarin and DOACs and between different DOACs was common which could indicate adverse events or affordability issues. Aspirin coadministration with anticoagulant therapy was present in 1 of 3 patients and is a potential medication safety intervention for anticoagulation providers.

Keyphrases

venous thromboembolism
direct oral anticoagulants
atrial fibrillation
end stage renal disease
low dose
healthcare
newly diagnosed
cardiovascular events
risk assessment
patient reported outcomes
adverse drug